New transplant drug tested to stop Body's attack on donated kidneys
NCT ID NCT06365437
Summary
This study tested a new drug called TCD601 to see if it's safe and how it works compared to standard treatment in people who just received a kidney transplant. The goal was to help prevent the body's immune system from rejecting the new kidney. The trial was stopped early and involved 33 adult participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital Universitari de Bellvitge
Barcelona, 08907, Spain
-
Innsbruck Medical University
Innsbruck, A-6020, Austria
-
Karolinska University Hospital
Stockholm, Huddinge, 14157, Sweden
-
Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
-
Skåne University Hospital
Malmo, 20502, Sweden
-
University of Vienna
Vienna, 1090, Austria
Conditions
Explore the condition pages connected to this study.